Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1852887A details a novel asymmetric copper complex for high-selectivity cyclopropanation, offering cost reduction in pyrethroid manufacturing and reliable supply chain solutions.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Novel three-step asymmetric synthesis route for high-purity (S)-rivastigmine intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112573996B reveals a novel copper-catalyzed route for high-purity L-menthol. Discover cost-effective manufacturing and scalable supply chain solutions.
Discover advanced Pd-catalyzed synthesis for chiral beta-lactams. High enantioselectivity and scalable processes for reliable pharmaceutical intermediates supply chains.
Novel organoaluminum-catalyzed reduction method for high-purity Nebivolol intermediates, offering superior chiral selectivity and simplified processing for pharmaceutical supply chains.
Patent CN110981707A details a novel isomerization method for high-purity chiral citronellal. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN115819387A details a novel Ru-catalyzed route for S-Pro-Xylane, offering high purity and safety for cosmetic manufacturing supply chains.
Novel tetrapeptide-catalyzed asymmetric Aldol synthesis for high-purity pharmaceutical intermediates. Cost-effective route to pantolactone with superior enantioselectivity.
Novel biphenanthrene skeleton catalyst offers high enantioselectivity for spiroketal manufacturing, ensuring supply chain stability and cost efficiency.
Patent CN101166708B details a high-yield copper-catalyzed method for (R)-muscone using novel phosphoramidite ligands and enolate scavengers, offering cost-effective scale-up potential.
Patent CN101157655A details a novel cinchona alkaloid-catalyzed route for (4S,5R)-half esters, offering superior yield and enantioselectivity for scalable biotin production.
Patent CN104974001A details a novel cinchona alkaloid-catalyzed route for high-purity beta-branched alpha-amino esters, offering significant supply chain and cost advantages.
Patent CN102219803A details a novel nitrone-based route for Ezetimibe intermediates, offering superior stereocontrol and reduced raw material consumption for pharmaceutical manufacturing.
Patent CN104031050A reveals high ee synthesis. Offers cost reduction and supply reliability for pharma intermediates manufacturing.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Patent CN115109759B reveals novel LsCR mutants for chiral alcohol synthesis. Achieve superior stability and yield for reliable pharmaceutical intermediate supply chains.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Patent CN1360574A details a novel route for tricyclic aminoalcohol derivatives featuring asymmetric reduction. This process offers significant cost reduction and improved supply chain reliability for pharmaceutical manufacturing.